Noncompaction Cardiomyopathy

This MedLibrary.org supplementary page on Noncompaction Cardiomyopathy is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Non-compaction cardiomyopathy (NCC),sometimes known as "spongiform cardiomyopathy" is a rare congenital cardiomyopathy that affects both children and adults. It refers to a type of cardiomyopathy where the myocardial development is hindered while the baby is in the womb during the embryogenesis stage [1] [2]. This hindrance begins to occur around the 8 week mark in the womb. The myocardium at this period of development is often referred to looking like a sponge as it is still a meshwork of interwoven myocardial fibers. This is beneficial at this stage as there is an increased surface area which allows perfusion of the myocardium from the left ventricular cavity. However as the embryo grows the myocardium should begin to be compact, in the case of NCC though the heart fails to fully compact leaving the myocardium to still have a spongy form.

Symptoms can range however are often a result of a poor pumping performance by the heart. The disease can be associated with other problems with the heart and the body or by itself

Noncompaction of ventricular myocardium is recently included in the 2006 classification of cardiomyopathies as a genetic cardiomyopathy [3].

Contents

Description

Non-compaction cardiomyopathy can affect both ventricular walls of the heart either separately or together. However, in general it only affects the wall of the left ventricle and therefore is sometimes known as left ventricular noncompaction. Due to its recent establishment as a diagnosis, and it being unclassified as a cardiomyopathy according to the WHO, it is not fully understood how common the condition is. Some reports suggest that it is in the order of 0.12 cases per 100,000. The low number of reported cases though is due to the lack of any large population studies into the disease and have been based primarily upon patients suffering from advanced heart failure. A similar situation occurred with Hypertrophic cardiomyopathy which was initially considered very rare; however is now thought to occur in one in every 500 people in the population.

Again due to this condition being established as a diagnosis recently, there are ongoing discussions as to its nature, and to various points such as the ratio of compacted to non-compacted at different age stages. However it is universally understood that non-compaction cardiomyopathy will by characterized anatomically be deep trabeculations in the ventricular wall, which define recesses communicating with the main ventricular chamber. Major clinical correlates include systolic and diastolic dysfunction, associated at times with systemic embolic events. (Weiford et al.2004)

Symptoms

Subjects' symptoms from non-compaction cardiomyopathy range widely. It is possible to be diagnosed with the condition, yet not to suffer from any of the symptoms associated with heart disease [1]. Likewise it possible to suffer from serve heart failure [2], which even though the condition is present from birth, may only manifest itself later in life.[1]

  • Breathlessness
  • Fatigue
  • Swelling of the ankles
  • Limited physical capacity and exercise intolerance

Two conditions though that are more prevalent in noncompaction cardiomyopathy are: tachyarrhythmia which can lead to Sudden Cardiac Death and clotting of the blood in the heart.

Other Complications

The presence of NCC can also lead to other complications around the heart and elsewhere in the body. These are not nesesarily common complications and no paper has yet commented on how frequently these complicationcs occur with NCC as well.

Misdiagnosis

In a recent studycitation needed carried out on 53 patients with the condition in New York, 42 had been diagnosed with another form of heart disease and only in the most recent 11 cases that ventricular noncompation was diagnosed and this took several echocardiograms to confirm. The most common misdiagnoses were:

The high number of misdiagnoses can be attributed to non-compaction cardiomyopathy being first reported in 1990; diagnosis is therefore often overlooked or delayed. Advances in medical imaging equipment have made it easier to diagnose the condition, particularly with the wider use of MRIs.

Prognosis

Due to non-compaction cardiomyopathy being a relatively new disease, its impact on human life expectancy is not very well understood. In a 2005 study [2] which documented the long term follow up of 34 patients with NCC, 35% had died at the age of 42 +/- 40 months with a further 12% having to under go a heart transplant due to heart failure. However, this study was based upon symptomatic patients referred to a tertiary care center, and so were suffering from more severe forms of NCC than might be found typically in the population. As NCC is a genetic disease, immediate family members are being tested as a precaution which is turning up more supposedly healthy people with NCC who are asymptomatic. The long term prognosis for these people is currently unknown.

Management

One paper [4] has listed the various types of management of care that have been used for various types of NCC. These are similar to management programs for other types of cardiomyopathies which include the use of ACE inhibitors, beta blockers and aspirin therapy to relieve the pressure on the heart, surgical options such as the installation of pacemaker is also an option for those thought to be at a high risk of [Cardiac arrhythmia|arrhythmia] problems.

In severe cases, where NCC has led to heart failure, a heart transplant may be necessary.

Images

See also

Barth syndrome, Emery-Dreifuss muscular dystrophy, myotubular myopathy, genes responsible for NCC are located also in the area that cause these conditions.

Links

References

  1. ^ a b c Espinola-Zavaleta, Nilda. (2006). "Non-compacted Cardiomyopathy: Clinical-Echocardiographic Study" (webpage). Cardiovasc Ultrasound 4 (1). Medscape. Retrieved on 2007-06-13. 
  2. ^ a b c Oechslin, Erwin (2005). "Non-compaction of the Left Ventricular Myocardium - From Clinical Observation to the Discovery of a New Disease" (webpage). Retrieved on 2007-06-13. 
  3. ^ Maron, Barry. (2006). "Contemporary Definitions and Classification of the Cardiomyopathies" (webpage). American Heart Association Journals 113 (14). American Heart Association t. doi:10.1161/CIRCULATIONAHA.106.174287. PMID 16567565. 113:1807-1816. Retrieved on 2007-06-13. 
  4. ^ Lorenzo Botto, MD (2004-Sept). "Left Ventricular Non-compacted" (PDF). Retrieved on 2007-06-13.

Wikipedia content modification information:

  • This page was last modified on 21 July 2008, at 14:32.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Noncompaction Cardiomyopathy".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.